Trial comparisons

curl "https://conductscience.org/api/comparisons/v1?page=159"

Response

The first 2 of this page's 20 results. GET /api/comparisons/v1?page=159

{
  "data": {
    "total": 85013,
    "results": [
      {
        "id": "NCT00003830-305607ae",
        "title": "Arm I:Sentinel Node Resection+Conventional Axillary Dissection vs Arm II: Sentinel Node Resection Followed by Node Examination: Morbidity - Number of Participants With Residual Arm Volume Difference",
        "summary": "314 of 1136 against 192 of 1151; risk difference 11.0 points, 95% interval 7.6 to 14.3; NCT00003830, Surgery to Remove Sentinel Lymph Nodes With or Without Removing Lymph Nodes in the Armpit in Treating Women With Breast Cancer",
        "record": "/library/comparisons/NCT00003830-305607ae",
        "nct_id": "NCT00003830",
        "kind": "outcome",
        "participants": 2287,
        "risk_difference": {
          "value": 0.10959698241578053,
          "lower": 0.07570672079313154,
          "upper": 0.1432331139406867
        },
        "group_1": "314 of 1,136",
        "group_2": "192 of 1,151",
        "difference": "11.0 points",
        "interval": "7.6 to 14.3",
        "trial_title": "Surgery to Remove Sentinel Lymph Nodes With or Without Removing Lymph Nodes in the Armpit in Treating Women With Breast Cancer"
      },
      {
        "id": "NCT00346073-02f59107",
        "title": "Boostrix Group vs Adacel Group: Number of Subjects With Serious Adverse Events (SAEs).",
        "summary": "9 of 1522 against 2 of 762; risk difference 0.3 points, 95% interval -0.4 to 0.9; NCT00346073, Safety and Immunogenicity of GSK's Tdap Vaccine (Boostrix) in Adults Aged 19 to 64 Years",
        "record": "/library/comparisons/NCT00346073-02f59107",
        "nct_id": "NCT00346073",
        "kind": "outcome",
        "participants": 2284,
        "risk_difference": {
          "value": 0.0032886000945019853,
          "lower": -0.004152249300190166,
          "upper": 0.008908194643430064
        },
        "group_1": "9 of 1,522",
        "group_2": "2 of 762",
        "difference": "0.3 points",
        "interval": "-0.4 to 0.9",
        "trial_title": "Safety and Immunogenicity of GSK's Tdap Vaccine (Boostrix) in Adults Aged 19 to 64 Years"
      }
    ],
    "no_events": 33758,
    "columns": [
      {
        "key": "title",
        "label": "Comparison"
      },
      {
        "key": "group_1",
        "label": "With the outcome",
        "under": "group_2"
      },
      {
        "key": "difference",
        "label": "Risk difference, 95% interval",
        "under": "interval"
      },
      {
        "key": "participants",
        "label": "Participants"
      },
      {
        "key": "nct_id",
        "label": "Trial",
        "under": "trial_title"
      }
    ],
    "order": "Most participants first",
    "kinds": {
      "all": 85013,
      "outcome": 33568,
      "serious-adverse-events": 31897,
      "deaths": 19548
    }
  },
  "release": "trial-comparisons-2026-03-23-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "No license stated"
    }
  ],
  "next": "/api/comparisons/v1?page=160",
  "request_id": "lR290NZK4Pt7KGoV"
}